Trending...
- Tomorrow's World Today Shines Bright with Four Telly Awards at the 46th Annual Telly Awards
- Deadline Extended: More Time to Submit Your Proposal for the OpenSSL Conference 2025
- Detroit Grand Prix High Profile Media Exposure, $100 Million Financing for Major Acquisition & Growth Strategy; Remote Lottery Platform: Lottery.com
PHILADELPHIA, June 3, 2025 /PRNewswire/ -- Berger Montague advises shareholders of Pfizer Inc. ("Pfizer" or the "Company") (NYSE: PFE) about an investigation into Pfizer's Board of Directors for potential breaches of fiduciary duties to Pfizer and its shareholders in connection with the Company's marketing and sale of Depo-Provera.
Shareholders of PFIZER may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or visit: https://investigations.bergermontague.com/pfizer/
More on The PennZone
Berger Montague's investigation is focused on whether Pfizer's Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's marketing and sale of Depo-Provera, an injectable used for contraception or to treat endometriosis, as well as other indications. Sources have reported on potential links between long-term use of the Depo-Provera and an increased risk of meningiomas, a type of brain tumor.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in shareholder litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Shareholders of PFIZER may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or visit: https://investigations.bergermontague.com/pfizer/
More on The PennZone
- First AI Marketing Platform Built Specifically for Small Businesses Launches Public Beta
- Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado
- Feldman Shepherd Honored As a 'Champion of Justice' By Community Legal Services
- Rediscovered Christopher Lee Recording 'Elenore' Re-Released to Mark 10th Anniversary of His Passing
- Doral Renewables Partners with American Farmland Trust to Expand Smart Solar℠ Initiative
Berger Montague's investigation is focused on whether Pfizer's Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's marketing and sale of Depo-Provera, an injectable used for contraception or to treat endometriosis, as well as other indications. Sources have reported on potential links between long-term use of the Depo-Provera and an increased risk of meningiomas, a type of brain tumor.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in shareholder litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Filed Under: Business
0 Comments
Latest on The PennZone
- ESG Inc. (OTC Markets: ESGH) Files Application to Uplist to Nasdaq Capital Market
- Western Carolina Emergency Network Accepts 2025 ReadyCommunities Partnership/CCROA National Service Award for Collaboration to Augment Local Response
- Pregis Empowers Foam-in-Place Customers to Fight Water Insecurity with Inspyre Film
- Exeter Smiles in Allentown Enhances Patient Care with DIBS AI Technology
- ATMAE and AGC Education & Research Foundation Announce Strategic Collaboration to Expand Scholarshi
- AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names
- Elliott Entertainment LLC & GCI Film Present Dionne Warwick At NYC's Apollo Theater "Don't Make Me Over, One Night Only", June 27th, 2025
- Fusion Marketing Group Celebrates 15 Years of Transforming Healthcare Recruitment Marketing
- Century Fasteners Corp. Exhibiting at the 2025 International Paris Air Show
- The World's No.1 Superstar™ Silences His Own Husband with Legally Binding NDA — "Call Him Mr. Sidow Sobrino" Now Law
- TRICOR Insurance Earns 2025 Great Place To Work Certification™
- Power Up Church Launches "The Power Core": A Bold New Giving Model Energizing Real-World Impact
- Broadway Icon Laura Bell Bundy Joins Mahaffey Summer Camp for Special One-Night Event
- Hanover Country Club Pool Season Off to a Splashing Start After Grand Opening
- Levitt Pavilion Los Angeles Summer Concert Series 2025
- Colonna Contemporary Launches Bold New Initiative: Contemporary Art as a Civic Catalyst on the Main Line
- Potential Short Squeeze Following Successful Exposure at Detroit Grand Prix; $100 Million Financing for Major Acquisition and Growth; Lottery.com Inc
- Shelter Structures America Appoints Shannon Heller as New Inventory Manager, Bolstering Operational Excellence in the Commercial Tent Industry
- International Wealth Success Names Pacific21 as Exclusive Strategic Partner for Asia-Pacific Ma